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Abstract 
The pentafluorosulfanyl group (SF5) is a highly stable chemical function which has been attracting a 
great deal of interest owing to its peculiar chemical, structural, physicochemical and biological 
properties. Progress in the area of SF5-compounds has been somewhat hindered by the lack of 
straightforward lab-scale synthetic methods for introducing the SF5-group into organic molecules. 
However, recent synthetic progress, the availability of some SF5-building blocks from commercial 
suppliers and the discovery of interesting properties of SF5-substituted molecules in materials 
science, biology and drug discovery are giving new momentum to research in this fascinating area of 
fluorine chemistry.  Synthesis, reactivity and biological properties of SF5-substituted organic 
molecules are herein reviewed with an emphasis on the work published after year 2000.  
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1. INTRODUCTION 
Pentafluorosulfanyl (SF5) compounds are considered to be organic derivatives of sulfur hexafluoride 
SF6. Both in SF6 and in SF5-compounds the sulfur atom is in hypervalent hexacoordinated state with 
an octahedral geometry of the ligands. The pentafluorosulfanyl group has remarkable chemical 
stability and compounds incorporating this group often possess advantageous and interesting 
properties, including high thermal, hydrolytic and chemical stability, high density, high lipophilicity 
and biological activity [1, 2]. Some of these properties are also to some extent typical of the 
trifluoromethyl group, to which the SF5 has been often compared. However, the SF5 is not just an 
exotic and “larger” version of the trifluoromethyl group, i.e. a “super-trifluoromethyl group” as it 
was dubbed recently [3]. 
The SF5 group properties are fascinating, peculiar and to a large extent largely unexplored, 
particularly in the biomedical field and in drug discovery. This review article is focused on small 
organic molecules having an SF5-carbon bond, i.e. inorganic SF5-chemistry and SF5-substituted 
polymers will not be discussed. The review is structured in three main sections: (1) Synthesis of SF5-
containing molecules (primary reactivity); (2) Reactions of SF5-containing molecules (secondary 
reactivity); (3) Biological properties. Different aspects of the chemistry and properties of SF5-
compounds have been reviewed, mainly in book chapters [4–9]. To our knowledge the most recent 
general review covering SF5-compounds dates back to 2005 [10] and comprehensively covers the 
literature until 2000, with scattered references to articles published in the following two years. This 
review will therefore cover the literature published after 2000, but important previous work will be 
reviewed too, especially on the preparation of SF5-compounds, which remains the “Achille’s heel” of 
this chemistry. 
2. SYNTHESIS OF SF5-COMPOUNDS (PRIMARY REACTIVITY) 
This section will review the “primary reactivity” of SF5-compounds, i.e. the ex-novo synthesis of 
different classes of SF5-compounds via (1) pentafluorosulfanylating agents or (2) fluorination of 
suitable precursors. Sulfur hexafluoride (SF6) is generally not useful for the preparation of SF5-
compounds. Therefore, the two main strategies for installing an SF5 group into organic molecules are 
(1) straight introduction of an SF5 group using a pentafluorosulfanylating agent on suitably 
functionalised substrates, such as alkenes, alkynes or an aromatic moieties, generally through radical 
chemistry, and (2) fluorination of a thiol, sulphide or disulfide function.  
2.1. Pentafluorosulfanylating agents 
The most important reagents for introducing an SF5 group into organic molecules are the two SF5X 
halides: SF5-Cl, first prepared in 1959 [11], and the more reactive SF5-Br, obtained for the first time in 
1965 [12]. The least reactive and highly toxic dimer F5S-SF5 has been also occasionally reported as a 
pentafluorosulfanylating agent  [13–15]. SF5Cl is thermally stable up to 400 °C in inert vessels, and is 
not hydrolysed by water or aqueous acids, but undergoes decomposition at lower temperatures in 
the presence of ultraviolet light and in alkaline solutions. SF5Br is less thermally stable and 
decomposition starts at 150 °C. 
One of the most recent improvements of the preparation of SF5Br was developed by Gard et al. who 
reported that a slow reaction (6-11 days at r.t.) between molecular bromine and BrF3 in the presence 
of cesium fluoride, followed by an even slower reaction of the resulting BrF with SF4 (36 days at r.t. 
or 20 days with moderate heating) afforded high yields (99.6% and 88.2%, respectively) of SF5Br [16]. 
Replacement of CsF with dry and carefully powdered KF was reported to be a key factor in the 
improvement of the preparation of SF5Cl, using the reaction between SF4 and Cl2 (Scheme 2) [17]. 
However, recently a more convenient synthetic method for the preparation of both SF5Cl and SF5Br 
was reported in the patent literature [18]. According to this protocol, dry KF, sulphur powder and Cl2 
were mixed in a reactor in the presence of Br2 which apparently acted as a catalyst (no reaction took 
place in the absence of Br2), affording excellent yields of SF5Cl after two to three weeks at r.t. The 
reaction was found to take place through the formation of SF4 as an intermediate (Scheme 1). 
Analogously, SF5Br was prepared in good yields by reaction of AgF, SF4 and Br2, but the latter in this 
case was a true reagent and was consumed in the process (Scheme 2).  
 
Scheme 1 
 
 
Scheme 2 
The dimer (SF5)2 can be efficiently prepared (99% yield) by photochemical decomposition of SF5Br in 
a quartz vessel (Scheme 3) [19]. 
 
Scheme 3 
The chemistry of SF5-X compounds above is dominated by the proclivity to form the SF5
. radical. In 
particular, the pentafluorosulfanyl radical can be generated from (SF5)2 under thermal conditions 
(heating to 125-140 °C), from SF5Cl using photo-irradiation or heating in the presence of a peroxide 
catalyst, and from the more reactive SF5Br by action of light or heating even without a catalyst. Less 
practically from the synthetic angle, it is also possible to generate this radical by microwave heating 
or electrical discharge from SF6 [10]. 
2.2. Synthesis of alkyl and fluoroalkyl SF5-compounds 
This chapter reviews the preparation of compounds having an SF5C(sp
3) bond. The first efforts 
directed at the synthesis of simple fluoroalkyl-SF5 compounds dates back to the 1950s when CF3SF5 
was obtained from both CH3SH and CS2 by reaction with CoF3 in yields up to 40% [20]. In the 
following years, several electrochemical fluorination versions of the same process were also 
published [21–23]. 
The fluoromethyl analogue was prepared in very good yields (86%) by AgF2 promoted fluorination of 
a N,N-bistrifluoromethyl sulfenamide (Scheme 4) [24]. 
 Scheme 4 
In a seminal contribution to the chemistry of SF5-compounds, Case et al. reported that SF5Cl is able 
to add thermally to a wide range of olefins, affording the corresponding SF5-alkanes incorporating a 
-chlorine atom (Scheme 5) [25]. 
 
Scheme 5 
Although SF5Cl has been reported to react with tri- or tetra-fluoroethylenes in the presence of a 
radical initiator to provide the corresponding saturated addition products, no reaction was observed 
with hexafluoropropylene. To accomplish this chloro-pentafluorosulfanylation reaction, the 
reactants were submitted to photochemical irradiation (Scheme 6) [26] (for related chemistry see: 
[27]).  
 
Scheme 6 
Addition of SF5Br to tetrafluoroethylene and other fluoroethylenes was also reported to take place 
[28] and later on was used to prepare SF5-fluoropolymers [29].  
 
SF5Br was found to react with 1,2-difluoroethylene through a radical non-stereospecific addition, 
resulting from a homolytic cleavage of the F5SBr bond, as demonstrated by the fact that both trans 
and cis olefins afforded a mixture of erythro and threo diastereomeric products, in similar ratio 
(Scheme 7) [30].  
 Scheme 7 
Other fluoroolefins, such as 3,3,3-trifluoropropene and chlorofluoroethylenes, were also shown to 
react with SF5Br leading to the corresponding addition products [31]. Bromo- and bromofluoro-
ethylenes were also found to undergo addition of SF5Br [32].  
SF5-CF2CF2-Ph was synthesised by means of SF5Br addition to CF2=CF-Ph followed AgBF4 promoted 
displacement of the secondary bromine atom by fluoride [33]. 
The scope of the methodology was subsequently expanded to a series of ortho-, meta- and para-
(SF5-perfluoroethyl)benzene derivatives. In fact, regioselective photochemical addition of SF5Br to 
the corresponding CF2=CF-Aryl substrates, followed by AgBF4 treatment afforded the target 
compounds in moderate to good yields (Scheme 8 and Table 1) [34]. 
 
Scheme 8 
Table 1 
Entry R1 Reaction 
time 
% Yield of SF5(CF2)2C6H4-
R1 
1 m-Br 18 h 53 
2 p-Br 25 h 53 
3 p-Cl 20 h 52 
4 P-CH3 48 h 41 
5 p-CF3 20 h 22
a 
6 p-NO2 51 h 80 
7 o-F 17 h 82 
8 o-CF3 18 h 74 
9 o-CH(CH3)2 18 h 67 
a 
Low yield due to volatility of product 
 
In the presence of two different terminal C=C bonds, one hydrogenated and one perfluorinated, 
SF5Br added to the former through a thermally induced radical process (Scheme 9) [35]. 
 
Scheme 9 
Bis-SF5-ethenes were obtained by SF5Br addition to the mono-SF5 precursor upon heating to 70 °C. 
No reaction was observed with fluorinated analogues like SF5-CF=CF2 (Scheme 10) [36]. 
 
Scheme 10 
Since SF5-I was unknown, SF5-iodoperfluoroalkanes were obtained by reaction of (SF5)2 (1.1 equiv) 
with (ICF2)2 (1.1 equiv) and tetrafluoroethylene (1 equiv) in a stainless steel vessel at 155 °C. The 
reaction occurred through a radical process and produced minor amounts of 4-iodo-perfluorobutyl-
SF5 as a co-product (Scheme 11) [15]. A related process was previously used for the preparation of 
SF5-telomers [14].  
 
Scheme 11 
 
SF5Cl was found to add to electron-rich and very reactive vinyl acetate and also with allyl acetate 
affording good yields of the corresponding primary SF5-adducts, which were then subjected either to 
oxidation to yield SF5-acetate or to elimination of hydrochloric acid to give -SF5-allyl alcohol (no 
epoxide formation was observed). More reactive SF5-Br gave lower yields in the reaction with vinyl 
acetate under the same conditions above, owing to partial decomposition, but was found to react 
efficiently under photochemical irradiation using CCl3F as solvent. Rewardingly, SF5-Br was found to 
add to less reactive acrylate affording -SF5--Br-acrylate ( Scheme 12) [37]. 
 Scheme 12 
 
Addition of SF5Br to acrylic and methacrylic esters was reported to occur upon heating the reaction 
mixture in order to achieve completeness of the process. Interestingly, more activated ,-diethoxy 
ethyl acrylate did not afford the expected addition product upon reacting with SF5Cl but produced -
chloro-malonate, SF4 and fluoroethylene instead (Scheme 13 and Table 2) [38].  
 
Scheme 13 
 
Table 2 
Entry R1 X 
1 H t-Bu 
2 CH3 CH3 
3 CH2Cl C2H5 
4 n-C7H15 C2H5 
 
SF5Cl was described to add under photochemical irradiation conditions to a wide structural range of 
functionalised olefins, affording the corresponding terminal SF5-substituted -chloro adducts in 
variable yields (Scheme 14) [39–43]. 
 Scheme 14 
A long chain aliphatic system bearing an -SF5 group was obtained by SF5Cl addition to the 
corresponding -unsaturated acetate (Scheme 15)[44]. 
 
Scheme 15 
A wide range of -chloro SF5-alkyl compounds was obtained by Et3B-catalysed regioselective and 
highly diastereoselective radical addition of SF5Cl to alkenes, including internal ones. Yields were 
remarkably high (79-98%) and reaction conditions very mild, rendering this method very attractive 
for lab-scale preparation. Acrylates however did not afford the expected SF5Cl addition (partly due to 
cross-reactivity of Et3B with the ester moiety), whereas alkynes like phenylacetylene afforded lower 
yields (49%) of the corresponding SF5--chloroalkene and partial dimerization (Scheme 16 and Table 
3)[45].  
 
Scheme 16 
Table 3 
R1 R2 R3 % Yield 
H n-C6H13 H 95 
H n-C4H9 H 98 
H t-C4H9 H 96 
H C2H5 C2H5 89 
n-C3H7 H n-C3H7 95
b 
(CH2)4 (CH2)4 H 98
b 
H p-tolyl H 79 
H OAc H 98 
b 
One major diastereomer (>90% by NMR) 
 
Later on, the methodology was expanded to include the regioselective synthesis of functionalised 
SF5--chloro alkyl derivatives, incorporating C=C bonds and ester moieties (Scheme 17). Allene 
successfully underwent the reaction producing the 2-chloroallyl-SF5 product. The same strategy 
worked also when SF5Cl was replaced by SF5Br, and -Br SF5-alkanes could be obtained by this route. 
The use of SF5Br seemed to be more appropriate for the reaction with electron deficient alkenes 
[46]. 
 
Scheme 17 
Another synthetic application of this methodology eventually resulted in an efficient entry to 2-SF5-
naphthalene. One of the key steps was the Et3B-promoted addition of SF5Cl to benzobarralene [47]. 
Another substrate which underwent addition of SF5Cl under the same conditions is a furan-
acrylonitrile exo-adduct which afforded the corresponding SF5Cl-addition product in very good yields 
and 2:1 diastereomeric ratio (Scheme 18) [48]. 
 Scheme 18 
The scope of the methodology was further investigated and validated by Röschenthaler et al. who 
showed that the BEt3-promoted addition of SF5Cl is superior to the photochemical process on a 
range of olefins (Scheme 19 and Table 4)[49, 50].  
 
Scheme 19 
Table 4 
Entry R Method 
Reaction 
timea 
Yield 
(%) 
1 
 
a 8 25 
b 6 48 
2b 
 
a   
b 4 92 
3 
 
a 8 56 
b 4 91 
4 
 
a 6 84 
b 2 95 
a In hour 
b The volatility of olefin 2 meant that only method (b) was used 
 
The methodology was also used for the addition of SF5Br to different alkenes which afforded a series 
of compounds that showed interesting properties as liquid crystals (Scheme 20) [51]. 
 Scheme 20 
3-SF5-4-Bromo sulfolane was obtained by addition of SF5Br to sulfol-3-ene (Scheme 21) [52]. This 
molecule was then used as an efficient precursor of 2-SF5-butadiene (see Section 3.2, Scheme 75). 
 
Scheme 21 
Dihaloethylenes were found to react with SF5Br through a radical mechanism, producing different 
reaction outcomes depending on the nature of the halogen. Indeed, ClCH=CHCl afforded the 
expected standard 1:1 adduct, whereas BrCH=CHBr reacted in a more complex way affording two 
different products, one saturated and one unsaturated, the latter incorporating the SF5 group. 
Interestingly the reaction producing SF5-CH=CHBr was stereoconvergent and starting from a mixture 
of cis/trans olefins only the trans product was formed (Scheme 22) [53]. 
Scheme 22 
An important step forward in the synthesis of SF5-alkyl compounds was recently achieved by Welch 
et al. who reported that the use of CCl3F as a solvent can strongly improve the Et3B-catalysed 
addition of SF5Br to C=C bonds, using operatively simple conditions such as normal glassware, 
ambient pressure and a temperature of 0 °C (Scheme 23 and Table 5) [54].  
 Scheme 23  
Table 5 
Entry Conditionsa Solvent Ab B 
1 KF CH2Cl2 9 1 
2 - CH2Cl2 9 1 
3 SF5Br (sol in CH2Cl2) and KF CH2Cl2 9 1 
4 SF5Br (sol in CH2Cl2) CH2Cl2 9 1 
5 KF Pentane 7 3 
6 - CCl3F 4 6 
a All reactions, 0.1 eq. Et3B, 1.2 eq. SF5Br, Temp: -78 ºC to RT 
b Product ratio determined by 19F NMR 
 
The use of CCl3F as a solvent was then successfully extended to the Et3B-catalysed addition of SF5Br 
to various unsaturated esters, which produced the corresponding bromo-pentafluorosulfanylated 
esters in excellent yields (Scheme 24 and Table 6). The use of SF5Cl afforded lower yields, and 
addition of DBU resulted in efficient dehydrobromination of the products [54]. Addition of SF5Cl to 
allyl acetate was subsequently described to occur efficiently [55]. 
 
Scheme 24 
Table 6 
Entry R1 Reaction timea Yieldb 
1 C(O)Ot-Bu 20 94 
2 CH2C(O)OMe 10 85 
3 CH2CH2C(O)OEt 20 93 
4 CH2CH(CH3)C(O)OEt 10 92 
5 CH2OC(O)CH3 10 99 
a In minutes 
b Isolated, purified yield 
 
Dimethyl itaconate was also successfully reacted with SF5Br affording the expected addition product 
in good yields (Scheme 25) [56]. 
 
Scheme 25 
An interesting addition reaction of SF5Cl to a diene, occurring with concomitant transannular 
cyclization was recently reported by Röschenthaler et al. Without any radical initiation, the process 
affords low yields of the target SF5-substituted adamantane-type cyclised product, with the 
formation of significant amounts of dichloro and chlorofluoro-substituted by-products, which may 
arise from the dissociation of SF5Cl into FCl and SF4. However, upon UV irradiation the process 
delivered high yields of target SF5-compound. Under UV-irradiation also norbornadiene reacted with 
SF5Cl affording two diastereoisomers of the corresponding transannulated SF5-product, in ca. 3:1 
ratio. Finally, cycloocta-1,5-diene failed to produce transannulation, affording the product arising 
from simple addition of SF5Cl to one of the C=C bonds, in rather modest yields (Scheme 26) [57]. 
 
Scheme 26 
The addition of SF5Cl and SF5Br to vinyl silanes was reported to occur efficiently and under mild 
conditions. The authors were unable to assign unambiguously the regioisomery of the products on 
the basis of spectroscopic and analytical data (Scheme 27) [58].  
 Scheme 27 
Ketene was also found to be reactive towards SF5-Cl, affording SF5-acetyl chloride [59].  This 
intermediate was then used as a starting material for the preparation of SF5-ketene through 
hydrolysis followed by dehydration (Scheme 28) [60].  
 
Scheme 28 
 
2.3. Synthesis of aryl SF5-compounds 
This chapter reviews the preparation of compounds having an SF5-group attached to an aromatic 
residue. Following unsuccessful efforts to prepare aromatic SF5-compounds by Emeleus et al. [61], 
the first aryl-pentafluoride C6H5-SF5 was successfully obtained by Sheppard by action of AgF2 on 
(C6H5S)2 in Freon which produced the intermediate trifluoride, then converted into the target 
phenyl-SF5 upon heating to 130 °C (yields 5-14%) (Scheme 29) [62]. 
 
Scheme 29 
The same transformation was achieved 40 years later by using XeF2 as fluorinating agent (up to 25% 
yield) [63]. 
The scope of the reaction was subsequently extended to meta- and para-nitrophenyl-SF5 
compounds by using a Teflon reactor (5-14% yields), whereas the use of a copper reactor increased 
the yields to 15-30%. Interestingly, bis-3,5-SF5 nitrobenzene could be obtained, albeit in low yields, 
starting from the corresponding bis-sulfonyl chloride (Scheme 30) [64]. 
 Scheme 30 
A related methodology was used later on for the synthesis of two other nitro-substituted SF5-
benzenes (Yields 29-43%)   (Scheme 31) [65]. 
 
Scheme 31 
Elemental fluorine (10% F2 in N2), that was used to convert at room temperature aromatic nitrothiols 
and nitro-methylsulfides into the corresponding SF5 compounds in moderate yields (Scheme 32) 
[66]. Remarkable results were achieved by employing micro-reactors for fluorinations that were 
used to convert bis(m-NO2-phenyl)-disulfide and p-NO2-phenyl-SF3 into the corresponding SF5 
compounds at room temperature [67]. 
 
Scheme 32 
The first ortho-substituted SF5-benzene was synthesised by AgF2-promoted fluorination of the 
corresponding disulfide (Scheme 33), although the scope of the reaction seems to be limited 
because other structurally related substrates did not afford the desired SF5-compounds  [68]. A few 
years later, more ortho-fluorinated SF5-aryl compounds were obtained in low yields ( 10%) by 
treatment of a disulfide precursor with F2/N2 [69]. 
 
 
Scheme 33 
A remarkably more efficient synthesis of SF5-benzene was achieved by chlorination of cyclohexa-1,4-
diene with SO2Cl2 followed by treatment of the resulting dichloro-intermediate with SF5Cl and then 
easy aromatisation resulting from elimination of three molecules of HCl (Scheme 34) [70]. 
 
Scheme 34 
A conceptually related entry to SF5-benzene was developed starting from 3,6-diacetoxy-cyclohex-1-
ene, which upon treatment with SF5Br followed by aromatisation resulting from elimination of HBr 
and 2 molecules of acetic acid or water afforded the target SF5-benzene (Scheme 35) [71]. 
 
Scheme 35 
The method worked also when less reactive SF5Cl was used instead of SF5Br; in that case, 
cyclohexene was used as starting material followed by NBS-promoted dibromination of the 
intermediate 1-SF5-cyclohexene (Scheme 36) [71]. 
 
Scheme 36 
Very recently Umemoto et al. published a novel two-steps synthesis of SF5-aromatics, which appears 
to be a significant improvement over previous methods. The synthesis is based on the conversion of 
aryl-disulfides or thiols into the corresponding SF4Cl derivatives by action chlorine and potassium or 
cesium fluoride (Scheme 37). Subsequent treatment with a fluoride source such as ZnF2 or Sb(III/V) 
fluorides effectively produced a displacement of the chlorine atom by fluoride affording the target 
SF5-aryl compounds. Bis-SF5-aromatics could be also prepared from the corresponding thiols [72].  
 Scheme 37 
 
2.4. Synthesis of alkenyl, alkynyl and acyl SF5-compounds 
This section reviews the preparation of compounds having an SF5C(sp
2) or SF5C(sp) bond. The first 
example of addition of SF5Cl to an alkyne dates back to 1964 when Hoover and Coffman reported 
the formation of 1-SF5-2-Cl-ethylene from acetylene under thermal conditions (Scheme 38) [73]. The 
corresponding reaction with SF5Br was described 20 years later to afford 80% yield of F5SCH=CHBr 
[74]. 
 
Scheme 38 
Propyne and trifluoropropyne efficiently reacted with SF5Br affording the corresponding SF5-prop-1-
enes. The former, which is more activated, underwent reaction at r.t. affording a single isomer, 
whereas the latter required heating to 100 °C and longer reaction times, affording a mixture of E/Z 
isomers (Scheme 39) [75].  
 Scheme 39 
The addition of SF5Br to alkynes was also exploited as a means to prepare SF5-alkynes, which were 
obtained by treating the intermediate 1-SF5-2-Br-alkenes with KOH that resulted in an elimination 
reaction (Scheme 40) [76].  
 
Scheme 40 
 
Further SF5-acetylene derivatives were prepared by means of a conceptually related synthetic 
protocol based on Et3B-catalysed addition of SF5Cl to terminal alkynes, followed LiOH-promoted 
elimination (Scheme 41) [77]. 
 
Scheme 41 

The same methodology was recently used to prepare SF5-substituted acetylenes having liquid crystal 
properties (Scheme 42). The SF5-substituted -chloro-alkene intermediates were treated with LiOH 
in DMSO at 50 °C for 12 h resulting in the desired elimination of HCl which produced the target SF5-
alkenes in 65-72% yields [78].  
 Scheme 42 

-SF5-acrylate monomers were obtained by reaction of SF5Br with ethyl propiolate (Scheme 43) [79]. 
 
Scheme 43 
A conceptually different approach to an SF5-alkene was reported by Winter and Gard who described 
the silicic acid promoted isomerisation 3-SF5-4-sulfolene to the corresponding 3-sulfolene (Scheme 
44) [52]. 
 
Scheme 44 
One of the few acyl-SF5 compounds described so far was obtained by radical addition of (SF5)2 to 
oxalyl fluoride (Scheme 45). The resulting product was then used as an intermediate in the 
preparation SF5OC(O)F and SF5O2C(O)F [80].  
 
Scheme 45 
 
 
3. CHEMISTRY OF SF5-COMPOUNDS (SECONDARY REACTIVITY) 
This section will review the reactivity of “primary” SF5-building blocks, obtained as described in 
Section 2, for producing more complex SF5-derivatives (secondary reactivity). 
3.1. Reactions of SF5-alkanes. 
The reactivity of SF5-alkanes, i.e. derivatives having a pentafluorosulfanyl group bound to an sp
3-
carbon which are generally obtained by addition of SF5X to the parent alkenes (see Section 2.2), is 
dominated by the -elimination of HX to afford the corresponding SF5-alkenes. De Marco and Fox 
described the KOH-promoted elimination of HCl from -chlorodifluoromethyl-SF5-compounds 
(Scheme 46) [27]. 
 
Scheme 46 
This reactivity has been extensively exploited from 2000 to date for preparing a number of 
structurally diverse SF5-alkenes, using a wide range of different bases and conditions, as summarised 
in Table 7. 
Table 7 
Entry Starting material Product [Ref] Base / Temp Yield
a 
(%) 
Comments 
1  [44] NaOMe / r.t. 91 
 
2 
 [79] 
NaOCH3 / 0 ºC 71 
Two isomers in 
ratio: 3:97 
3 
 [70] 
NaOEt /r.t. 79 
 
4 
 [71] 
K2CO3 / 56 ºC 98, 70
b 
Heating to 265 ºC: 
 
5 
 [71] 
KOC(CH3)3 / r.t. 71 
 
6 
 [81] 
K2CO3 / 60 ºC 
n=1, 79 
n=2, 86 
 
7 
 [81] 
K2CO3
 
/ 55 ºC 50 
Heating to 75-80 ºC 
 
8  [40] KOH / 30 ºC 67 
 
9 
 [41] 
KOH / 30 ºC  
R= H, CH3 
10  [41] KOH / 30 ºC 
 
 
11 
 [82] 
K2CO3 / 60 ºC 87 
 
12 
 [82] K2CO3 / 60 ºC 90 
 
13  [46] NaOMe / r.t. 76 
 
14 
+  
+ 
[48] 
LiOH * H2O / r.t. 96 
 
15 
 [51] 
KOH / 35 ºC 
R=C3H7 74 
R= C5H11, 84 
 
16 
 [51] 
KOH / 35 ºC 97 
 
17 
 [51] 
KOH / 65 ºC 
R=C3H7 87 
R= C5H11, 89 
 
18 
 [51] 
KOH / 65 ºC 96 
 
19 
 [51] 
KOH / 65 ºC 81 
 
20 
 [47] 
NaOMe / 50 ºC 95 
 
21 
 
[52] AgOTs / 82 ºC 52 
By-product 
 
22 
 [49] K2CO3 / 50 ºC 
R= Cy, 91 
R= i-Pr, 88 
R= (CH2)2Ph 87 
R= CH2Cy, 78 
 
a Total yield 
b Starting from the trans isomer, 98 % of trans product has been obtained. Starting from the cis, 70% of cis product has been obtained  
 
SF5-cylopentadiene was obtained as a mixture of two tautomeric forms from two different starting 
materials. In both cases elimination of HCl was the key step, followed by either a retro-Diels Alder 
reaction or a P2O5-promoted dehydration (Scheme 47) ([39]). 
 
Scheme 47 
 
1,3,4-Oxadiazoles incorporating SF5-perfluoroalkyl/alkyl substituents were synthesised starting from 
the corresponding SF5-containing carboxylic acids through the corresponding hydrazides which were 
coupled to a second carboxylic acid, and then submitted to intramolecular condensation (Scheme 
48) [83] . 
 Scheme 48 
 
Aliphatic SF5-substituted C-3 building blocks such as 3-Br-pentafluorosulfanyl-propane and 3-SF5-
propionic acid were prepared by radical reduction of the parent 2-Br-propionates followed by 
manipulation of the carboxy function (Scheme 49) [38]. A related halide displacement was reported 
to occur when SF5CF2CFBrPh was treated with AgBF4 affording SF5CF2CF2Ph together with AgBr and 
BF3 [33]. The scope of the method was subsequently extended to the synthesis of an array of 
SF5CF2CF2Ar compounds (Ar = substituted aryl groups) [34].  
 
Scheme 49 
 
An SF5-perfluoroalkyl thiol was obtained by SN2-reaction of thiolacetic acid with an -iodo precursor 
followed by LiAlH4 reduction (Scheme 50) [44]. 
 
Scheme 50 
Similarly, a series of quaternary trifluoromethanesulfonimide salts incorporating different N-
heterocyclic residues were prepared by SN2-reaction with the parent -iodo derivative followed by 
anion exchange (Scheme 51) [84]. Similar strategy was subsequently used to prepare energetic salts 
incorporating SF5-alkyl residues, heterocyclic rings and perchlorate, nitrate, and related counterions 
[85].  
 
Scheme 51 
A broad range of -SF5-alkyl building blocks were prepared by halogen displacement with O-
nucleophiles by treatment with the corresponding silver and alkali metal salts. Interestingly, 
treatment of 1-SF5-2-bromoethyl derivatives with AgOAc and acetic acid resulted in either 
elimination or in SN2 reaction depending on the presence or not, respectively, of a bromine atom in 
-position to the SF5. (3-SF5-propyl)malonate was then prepared from the corresponding bromide 
and decarboxylated to give -SF5-pentanoic acid (Scheme 52) [56]. 
 Scheme 52 
 
An extremely interesting development related to the preparation of SF5-substituted azides for click-
chemistry was recently reported (Scheme 53) [86]. SF5-Ethyl and propyl azides were synthesized by 
nucleophilic substitution of the parent tosylates with 1.2 equivalents of sodium azide at 60°C, 
whereas an attempt to reduce the reaction time by using a larger excess of azide and higher 
temperatures resulted in a rather unexpected concomitant SF5-displacement that afforded the bis-
azide derivative. The use of SF5-alkyl-bromides in the reaction with NaN3 gave poor results. The 
azides were reacted in situ with a series of terminal alkynes under classical “click-chemistry” 
conditions affording the target 1,2,3-triazoles in good yields.  
 
Scheme 53 
SF5-acetate and acetone were synthesised by hydrolysis of the -chloro acetate precursors in the 
presence of, respectively, methanol and water. Interestingly attempts to alkylate the -anion of SF5-
acetate were unsuccessful. Control experiments with the anion of -SF5-crotonate, which could not 
be alkylated either, suggested that the observed lack of reactivity may be due to the stabilising 
effect of the electron withdrawing SF5 group rather than to its steric bulk (Scheme 54)[46]. SF5-
Acetate was recently utilised by Dolbier et al. in the synthesis of energetic materials [87]. SF5-Acetyl 
chloride was also used as a starting material for the synthesis of high-energy SF5-nitro compounds 
[59]. 
 
Scheme 54 
 
Another example of SF5-substituted ketone was obtained by hydrolysis of SF5-tetrafluoroethyl-
benzene (Scheme 55)[88]. 
 
Scheme 55 
 
3.2. Reactions of SF5-alkenes: addition, addition-elimination, elimination and cycloaddition 
One of the first reactions involving SF5-alkenes, specifically SF5-CH=CHCl, was described in 1964. 
Photochemical addition of bromine followed by basic elimination produced a regioisomeric mixture 
of SF5-CBr=CHCl that was eventually reduced by zinc to SF5-acetylene in high yields (Scheme 56) [73]. 
 
Scheme 56 
Later on, the addition of HF, indirectly generated from KF + formamide, to SF5-difluoroethylenes was 
reported to produce a small array of -CF3-pentafluorosulfanyl compounds (Scheme 57) [27]. 
 
Scheme 57 
Perfluorinated -sultone was obtained by addition of SO3 to SF5-trifluoroethylene, and then 
hydrolysed with water at 45-60 °C producing the corresponding sulfonyl fluoride and CO2 + HF as co-
products (Scheme 58) [89]. This finding built on extensive previous work dedicated to the 
preparation of SF5-substituted -sultones and their conversion into fluorosulfonyl derivatives [90] 
(for a review see [91]). 
 Scheme 58 
 
An interesting example of the peculiar reactivity of SF5-dienes was described by Brel, who 
demonstrated that the SF5-substituted C=C bond is unreactive in the presence of an oxidant like 
MCPBA whereas another double bond in the same molecule, including a conjugated one, is 
epoxidised (Scheme 59)[81].  
 
Scheme 59 
A similar protective behaviour of the SF5 group towards C=C bond oxidation was observed for the 
treatment of SF5-allylic alcohols with Cr(VI) oxidants which resulted exclusively in the oxidation of 
the carbinol function (Scheme 60) [41]. 
 
Scheme 60 
 
However, hypochlorite oxidation of SF5-trifluoroethylene successfully produced the corresponding 
epoxide. As the reaction involves the formation of an anionic intermediate, the SF5 group was found 
to facilitate the reaction and was more effective than a CF3 group in terms of negative charge 
stabilisation (Scheme 61) [92]. 
 
Scheme 61 
 
Similarly, SF5-dienes showed chemoselective reactivity towards cycloaddition reactions, affording 
under different conditions the corresponding 4,5-dihydroisoxazoles originated by exclusive reaction 
of the non-SF5-substituted C=C bond (Scheme 62) [41]. 
 
Scheme 62 
 
Treatment of SF5-alkenes with bromine did not result in addition across the C=C bond but rather in 
allylic bromination, confirming the lack of reactivity of SF5-substituted C=C bonds. The allylic 
bromides were submitted to base-elimination affording a set of terminally SF5-substituted buta-1,3-
dienes (Scheme 63) [49, 50]. 
 
Scheme 63 
The same kind of reactivity towards bromination was very recently observed in SF5-alkene systems 
deemed to be used for novel liquid crystals (Scheme 64) [78].  
 
Scheme 64 
  
SF5-1,3-dienes were prepared exploiting a key Wittig or Horner-Wadswarth-Emmons (HWE) 
reaction. The starting allylic alcohols were prepared by Grignard-reagent 1,2-addition to -SF5-
acrolein, which occurred in low to moderate yields (Scheme 65 and Table 8). 
 
Scheme 65 
Table 8 
Entry R 
Yielda 
(%)  
method A
 
Yieldb 
(%) 
method B 
1 C5H11 65 38 
2 C14H29 62 26 
3 Ph 60 30 
4 C6H11 30 16 
5 Allyl 33 32 
6 Bn 5c 2c 
7 Vinyl 0 53 
a Method A: In situ Grignard preparation 
b Method B: Addition of pre-formed Grignard reagent 
c GC yields 
 
Oxidation of the SF5-allylic alcohols to -SF5-oxo-compounds was achieved via PCC-oxidation in the 
presence of silica gel (Scheme 66). 
 
Scheme 66 
The target dienes were eventually obtained in generally good yields and as mixtures of regioisomers, 
either by Wittig or HWE reactions (Scheme 67 and Table 9). 
 
Scheme 67 
 Table 9 
Entry R Methoda 
Product Isomers 
formed 
Ratiob Yield
c 
(%) 
1 
H 
C (2Z,4E);(2E,4E) 16:84 72 
2 D (2Z,4E);(2E,4E) 2:98 46 
3 
C6H11 
C (2Z,4E);(2E,4E) 14:86 60 
4 D (2Z,4E);(2E,4E) 0:100 46 
5 
C14H29 
C (2Z,4E);(2E,4E) 43:57 57 
6 D (2Z,4E);(2E,4E) 39:61 74 
7 
Ph 
C (2E,4E);(2Z,4E) - 0 
8 D (2E,4E);(2Z,4E) 62:38 41 
a Method C: Wittig reaction; Method D: Horner-Wadsworth-Emmons (HWE) reaction 
b Determined by GC and confirmed by19F NMR 
c Combined yields 
 
Some 1,3-dienes were alternatively obtained by direct dehydration of the intermediate allylic 
alcohols or alternatively by elimination of the allylic bromides produced by dehydroxy-bromination 
with CBr4/triphenylphosphine (Scheme 68) [55].  
 
Scheme 68 
A series of useful SF5-alkene compounds was prepared from SF5-allyl alcohol, which was selectively 
oxidised to SF5-acrolein by action of CAN and then converted into a regioisomeric mixture of oximes, 
which were dehydrated to SF5-acrylonitrile (Scheme 69).   
 Scheme 69 
These compounds, as well as SF5-acrylates, were then employed as dienophiles in Diels-Alder 
reactions (Scheme 70) [42] (see also [43]) 
 
Scheme 70 
 
3-Chloro-1-SF5-propene demonstrated a peculiar reactivity. In fact, following its preparation from 
the corresponding SF5-allyl alcohol, the compound showed the expected SN2-type reactivity with 
azide and thiocyanate anions, whereas upon reaction with cyanide at r.t. a double-bond migration 
was observed instead. Supported by calculations, this behaviour was interpreted in terms of CN 
preferentially acting as a base rather than as a nucleophile (Scheme 71) [40].  
 
 
Scheme 71 
 
SF5-susbtituted C=C bonds proved to be reactive under Diels-Alder reaction conditions, and the 
corresponding cyclohexenes were obtained by reaction with 2,3-dimethyl-butadiene upon heating 
for 8-10 hr at 100-110 °C (Scheme 72) [41].  
 
Scheme 72 
A retro-Diels-Alder reaction was used to prepare 3-SF5-furane in good yields, with the concomitant 
formation of acrylonitrile as a co-product. 2-Methyl-3-SF5-furane was prepared following the same 
protocol (Scheme 73) [48]. 
 
Scheme 73 
 
In contrast, 2-SF5-benzobarralene did not undergo the expected thermal retro-Diels-Alder reaction 
to 2-SF5-naphthalene, therefore an indirect approach to the target compound was sorted out. A bis-
pyridyl tetrazine was submitted to Diels-Alder reaction with 2-SF5-benzobarralene affording the 
corresponding adduct, which underwent first a loss of N2 and then a retro-Diels-Alder affording the 
target compound , which proved to be thermally stable up to 250 °C (Scheme 74) [47].  
 
Scheme 74 
3-SF5-sulfolane was found to be a synthetic precursor of 2-SF5-butadiene and successfully used as a 
substrate in Diels-Alder reactions leading to an array of SF5-substituted cyclic compounds (Scheme 
75) [52].  
 
 Scheme 75 
 
3.3. Reactivity of SF5-alkynes 
A limited number of SF5-substituted heterocycles have been reported and many of them were 
obtained via dipolar cycloadditions involving SF5-alkynes. 1-SF5-Hex-1-yn underwent a tandem Diels-
Alder/retro-Diels-Alder reaction with 4-phenyl-oxazole that afforded 3-SF5-4-butyl-furane with the 
formation of cyanobenzene as a co-product (Scheme 76) [48]. 
 
 
Scheme 76 
 
SF5-Azoles, including pyrazoles and 1,2,3-triazoles, were synthesised by 1,3-dipolar cycloaddition 
reaction of diazomethane or azides, respectively, with different SF5-alkynes. The resulting 
compounds demonstrated interesting properties as energetic materials, with detonation properties 
similar to those of TNT. The SF5-group was shown to play an important role by increasing the density 
of these molecules and therefore their detonation performance (Scheme 77) [93].  
 
Scheme 77 
 
An SF5-triazole bearing a tetrazolyl substituent was analogously synthesised by cycloaddition 
reaction of a tetrazolyl-azide with SF5-acetylene (Scheme 78) [94].  
 
Scheme 78 
 
A broad range of dense stable energetic materials incorporating multiple 1,2,3-triazine units was 
prepared by addition of azides and polyazides with SF5-acetylene in generally good yields. The 
trifluoromethyl-analogues were also prepared and compared to the SF5-counterparts, which 
invariably showed more negative enthalpies of formation and higher densities (Scheme 79) [95]. 
 Scheme 79 
A series of SF5-alkynes, generated by base-elimination from the corresponding -chloro-alkenes (for 
another example see: [46]), were reacted with an azomethine ylide thermally obtained from N-tert-
butyl-carbomethoxy aziridine affording the corresponding dihydropyrroles which were then oxidised 
by DDQ to the previously unknown 3-SF5-pyrroles. In some case, it was also possible to cleave the N-
tert-butyl group by treatment with triflic acid (Scheme 80) [77]. 
 Scheme 80 
 
SF5-Pyrroles were synthesised through a reaction sequence involving 1,3-dipolar cycloaddition of 
SF5-alkynes with azomethine ylides, followed by DDQ-oxidation of the resulting pyrrolines. SF5-
thiophenes were also obtained by employing thiocarbonyl ylides as dipoles. In that case DDQ could 
not be used for the oxidation of the dihydrothiophenes to thiophenes, which was achieved by means 
of SO2Cl2 (Scheme 81) [96]. 
 
Scheme 81 
 
3.4. Reactivity of SF5-aromatic compounds. 
The reactivity of SF5-substituted aromatic compounds is dominated by (1) the meta-directing, 
deactivating inductive effect that the electron-withdrawing SF5 group displays in electrophilic 
substitution reactions, (2) the activating ortho- and para-effect displayed in nucleophilic substitution 
reactions. SF5-nitrobenzene is a key building block for the synthesis of aromatic pentafluorosulfanyl 
compounds. The original synthesis from aromatic nitrothiols and disulfides (see Section 2.3) was 
recently improved by Dolbier et al. who successfully achieved the nitration of SF5-benzene in high 
yields and meta-regiocontrol (Scheme 82) [70]. Meta-SF5-nitrobenzene was then reduced with 
Fe/HCl to the aniline, which was N-acetylated too. Meta-bromination of SF5-benzene was also 
performed in high yield and the resulting m-SF5-bromobenzene was para-nitrated in good yields. 
Eventually, the aniline derivative was synthesised using the same NO2-reduction conditions. 
 
Scheme 82 
Recently, a synthesis of 3,5-dinitro-SF5-benzene was reported in the patent literature [97]. The 
method relies on the dinitration of para-SF5-toluene, followed by oxidation of the methyl group to 
carboxylic function and finally thermal decarboxylation (Scheme 83).  
 Scheme 83 
A number of aromatic SF5-compounds were synthesised starting from the meta- and para-nitro SF5-
precursors, which were initially reduced to the corresponding anilines, and then submitted to a 
range of different reactions including Sandmayer iodination followed by Sonogashira alkynylation, 
Suzuki arylation and Heck olefination (Scheme 84) [66]. Interestingly, the authors demonstrated that 
4-SF5-aniline and 4-CF3-aniline show similar stability towards acid hydrolysis, namely treatment with 
concentrated sulphuric acid at 160 °C leads to hydrolysis of both CF3 and SF5 groups. However under 
basic conditions (2 N NaOH) the CF3 group was readily hydrolysed to CO2H whereas the SF5 group 
was perfectly stable. The authors rationalised this behaviour on the basis of electronic stabilisation 
of the planar difluoromethylene group resulting from fluoride elimination by the deprotonated para-
amino group. In contrast, the same stabilisation cannot occur for geometric reasons in the case of 
the SF5 group, because the sulphur atom has an octahedral geometry whereas the carbon atom in 
the-CF3 is tetrahedral. 
 Scheme 84 
 
A small library of ortho-substituted SF5-compounds was obtained starting from 2-fluoro-5-nitro-SF5-
benzene which is highly activated towards nucleophilic aromatic substitution and was therefore 
submitted to a range of reactions with different nitrogen-, oxygen- and sulphur-centered 
nucleophiles such as piperidine, potassium ethylate, ammonia, sodium thiolate affording the 
corresponding fluoride-substitution products (Scheme 85) [68]. 
 Scheme 85 
Related chemistry was used by Trasher et al. for the synthesis of a small array of SF5-aryl compounds 
from 3-nitro-4-chloro-pentafluorosulfanyl benzene. The chlorine atom was shown to be very 
reactive towards substitution with different nucleophiles that provided good yields of the 
corresponding nitro-compounds, which were reduced with Fe/HCl to the anilines. An interesting bis-
SF5-biaryl was also synthesised via Ullman-type coupling (Scheme 86) [65].  
 Scheme 86 
4-Chloro-3,5-dinitro SF5-benzene was submitted as well to nucleophilic substitution reaction with 
secondary amines affording good yields of the resulting tertiary amines (Scheme 87) [65].  
 Scheme 87 
An interesting observation on the reactivity difference between CF3 and SF5-compounds came from 
the reaction of the two 4-chloro-3,5-dinitrobenzene derivatives with potassium ethyl xanthate. In 
the CF3-compound also the nitro moiety was found to be a good leaving group affording the 
thianthrene via dimerisation of the intermediate aryl xanthate, whereas the SF5-compound 
underwent only loss of COS affording the monomeric ethylthio derivative (Scheme 88) [65]. 
 
Scheme 88 
Reaction of the same 4-chloro-3,5-dinitro-SF5-benzene with another S-centered nucleophile, i.e. 
ethyl thiolacetate, provided the expected nucleophilic substitution product which was subjected to 
intramolecular condensation affording a benzothiazole N-oxide (Scheme 89) [65].  
 
 
Scheme 89 
 
A wide range of SF5-perfluoroethyl-benzene derivatives were synthesised starting from SF5-
perfluoroethyl-benzene which was meta-nitrated, reduced to the corresponding aniline, and 
transformed into the key diazonium salt intermediate. Sandmayer-type chemistry was then used to 
functionalise the scaffold with a number of different functionalities including halogens, hydroxyl and 
acyloxy functions, SO2Cl, vinyl and azide groups (Scheme 90)[98, 99].The corresponding sulfonic 
acids were also obtained by treatment of the same substrate with chlorosulfonic acid [100]. 
 Scheme 90 
 
SF5-aryl compounds for liquid crystals applications were synthesised by Suzuki cross-coupling with a 
para-bromo-SF5-benzene derivative prepared from the parent aniline via Sandmayer bromination. 
An ether derivative was obtained by aromatic nucleophilic substitution, activated by the SF5-group, 
with an alkoxide (Scheme 91) [69]. 
  
Key: Synthesis of the liquid crystals; reagents and conditions:  I) 1. NaNO2 ,HBr, 0-5 °C; 2. CuBr, 85 °C; II) 
NaBO2· 8H2O, H2O, THF, cat. Pd(PPh3)4, reflux, 18 h (16 %); III) 1. t-BuLi, Et2O, -70 °C; 2 . B(OMe)3; 3. HOAc, 
H2SO4, 30% H2O2, -20 to 35 °C (crude product used for next step); IV) 1. CF3SO3H, CH2Cl2, 0 °C (5 min) to r.t. 
(30 min) to -70 °C; 2 . NEt3, CH2Cl2, -70 °C; 3. NEt3· 3HF,-70 °C; 4. Br2, CH2Cl2, -70 to -10 °C (7 %) 
Scheme 91 
A further derivative obtained from para-SF5-aniline, i.e. its phthalimide, was submitted to 
triboluminescence studies (Scheme 92) [101].  
 
Scheme 92 
SF5-substituted benzoic acids were synthesised in excellent yields from the corresponding bromo-
derivatives by reaction with 1-formyl-piperidine and tert-BuLi, followed by oxidation of the resulting 
benzaldehydes (Scheme 93) [102]. 
 
Scheme 93 
 An interesting example of vicarious nucleophilic substitution reaction involving SF5-nitrobenzenes 
and activated halides was exploited to synthesise a library of functionalised SF5-nitroaromatic 
derivatives. Treatment of -chloro or -bromo acetates, sulfones, phosphonates, acetonitriles or 
simple haloforms with an excess of tert-butoxide followed by reaction quenching either with 
hydrochloric acid or with another carbon electrophile afforded the corresponding mono- or di-
alkylation products, respectively. The reaction with para-SF5-nitrobenzene was regioselective 
producing exclusive meta-SF5 reaction, whereas the meta-regioisomer produced a mixture of two 
regioisomers with large predominance of the para-SF5 products (Scheme 94 and Table 10) [103]. 
 
Scheme 94 
 
 
 
 
 
 
Table 10 
Entry  X1 R1 R2 R3 X2 Yield
a 
(%) 
o -CH(R1)R2 / p -CH(R
1)R2 
ratio 
(relative to NO2) 
1 p-SF5 Cl H PhSO2   84  
2 p-SF5 Cl H CO2Et   76  
3 p-SF5 Cl H CO2Bu-t   91  
4 p-SF5 Cl Cl CO2Me   83  
5 p-SF5 Cl Me CO2Me   9  
6 p-SF5 Cl H P(O)(OEt)2   84  
7 p-SF5 PhO H CN   74  
8 p-SF5 Cl Cl Cl   74  
9 p-SF5 Br Br Br   74  
10 p-SF5 Cl H CO2Et PhCH2 Br 59  
11 p-SF5 PhO H CN CH3 I 57  
12 m-SF5 Cl H PhSO2   94
 c 96:4 
13 m-SF5 Cl H CO2Bu-t   94
 c 94:6 
14 m-SF5 Cl Cl CO2Me   79
 d 98:2 
15 m-SF5 Cl H P(O)(OEt)2   73
 c 95:5 
16 m-SF5 PhO H CN   73
c 85:15 
17b m-SF5 Cl Cl Cl   91
 d 96:4 
18b m-SF5 Br Br Br   84
 d 98:2 
19 m-SF5 Cl H PhSO2 CH2=CHCH2 Br 84  
20 m-SF5 Cl Cl CO2Me n-Bu I 0  
a Isolated yields 
b Determined by 19F NMR of the crude product mixture 
c  Relative to the sum of o -CH(R1)R2 and p -CH(R
1)R2  products 
d Relative just to the  o -CH(R1)R2 product 
 
The reaction mechanism is thought to involve deprotonation of the activated -halogen or -
phenoxy-nucleophile which adds in ortho-position to the nitro group. The intermediate anion, 
stabilized by delocalization of the negative charge onto the nitro-group, undergoes base-promoted 
elimination of HCl, HBr or PhOH producing a second anion that is eventually quenched affording the 
final alkylated products (Scheme 95). The position of the SF5-group determines the regioselectivity of 
the process. 
 Scheme 95 
 
SF5-Phenol derivatives could be also prepared by means of the same methodology, i.e. by submitting 
SF5-nitrobenzenes to vicarious nucleophilic substitution reaction with tert-butoxide anion and cumyl 
hydroperoxide (Scheme 96). Higher yield and a cleaner reaction were observed with p-SF5-
nitrobenzene [104]. 
 
Scheme 96 
Very recently, the same vicarious nucleophilic substitution strategy was used for preparing a series 
of heterocycles, exploiting a key reaction of 1,1,1-trimethylhydrazinium iodide in the presence of 
potassium tert-butoxide with para-SF5-nitrobenzene. The same products could be accessed from the 
meta-derivative by the same sequence (Scheme 97) [105].   
 Scheme 97 
In another example, SF5-nitrobenzenes were used as building blocks taking advantage of the good 
leaving-group nature of the nitro group activated by the pentafluorosulfanyl moiety. As expected, 
treatment of the more activated para-SF5-nitrobenzene with a wide range of nucleophiles occurred 
under milder conditions and afforded higher yields of the corresponding substitution products than 
the meta-SF5-isomers (Scheme 98 and Table 11) [106]. 
 
Scheme 98 
Table 11 
Entry  RM Time / h Yield
a 
(%) 
1 p-SF5 MeONa 
1 83 
2 m-SF5 5 52 
3 p-SF5 n-PrONa 
0.5 71 
4 m-SF5 1 41 
5 p-SF5 PhCH2OK 
1 96 
6 m-SF5 2.5 42 
7 p-SF5 PhOK 
17 59 
8 m-SF5 16 Traces
b 
9 p-SF5 MeSNa 
16 64 
10 m-SF5 21 Traces
b 
a Isolated yields 
b Detected by GCMS analysis in trace amounts  
 
4. BIOLOGICAL ACTIVITY OF SF5-SUBSTITUTED COMPOUNDS 
The SF5 group has been often referred to as a “super-trifluoromethyl group” [3] because as a matter 
of fact these two groups share many peculiar features, such as high electronegativity, steric bulk, 
thermal and chemical stability, lipophilicity, with the SF5-group slightly prevailing over the CF3 in all 
of these aspects. Some quantitative parameters for the two groups are summarised in the Table 12. 
Table 12 
 SF5 CF3 Ref 
Hammett constant 
P(electronegativity) 
+0.68 +0.54 [107] 
R (resonance 
contribution) 
0.11 0.12 [108]  
and references therein 
I (field effects) 0.55 0.39 
Hansch 
hydrophobicity 
constant   
1.51a 1.09a [109] 
Electronegativity 3.65 3.36 
[110]  
and references therein 
pKa
c 2.37b 2.94b [111] 
Volume 
49.2 cm3/mol 
(calculated in liquids) 
20.49 cm3/mol (van der 
Waals volume) 
[83] (SF5); 
[112] (CF3) 
and references therein  
a
: referred to the m-position of the substituent 
b
: referred to the p-position of the substituent
 
c
: Determination of acidity constant of Anilinium ions from optical density measurement 
 
 
Importantly, both the SF5 and CF3 groups are xenobiotic and their stability is very high under 
physiological conditions, which make them very interesting functions for biomedicine and drug 
discovery/development applications. Interestingly, whereas it is becoming increasingly clear and 
widely accepted that the CF3-group is a bioisosteric equivalent of an ethyl group [113], the 
corresponding features for the SF5-group have not been investigated in detail yet. However, it is 
apparent that the volume of the SF5 group is slightly less than that of a tert-butyl group, but 
remarkably larger than the CF3 volume (see also Table 12) [110]. In spite of these considerations, the 
SF5 group has been shown to behave often like a CF3 group, possibly because both would appear to a 
receptor site as highly fluorinated surfaces having similar electrostatic properties. However, also in 
this case the geometries are remarkably different, because the SF5 group will present a pyramidal 
electron density, whereas the CF3 will display an inverted cone of density [114]. For all of the reasons 
above it is reasonable to predict that future research will show that, besides some similarities, the 
SF5 and the CF3 group can impart distinct and peculiar biological properties to molecules. This is in 
line with recent results obtained by our group, showing that in two series of -CF3- and -SF5-aniline-
containing pyrazoles the SF5 compounds consistently had lower Ki for the CB1 receptor than the CF3-
counterparts in in vitro assays (Figure 1). This could be very roughly explained with a “better fit” of 
the SF5 group into the corresponding pocket of the CB1 receptor relative to the CF3 group, which 
confirms that the two groups are not “biologically” equivalent. The most potent compounds in the 
series displayed nanomolar Ki values for CB1, and are currently tested for their pharmacological 
properties [115]. 
 
 Figure 1 
 
These findings are in line with previous work that showed that SF5-analogues of the popular 
serotonin uptake inhibitors fluoxetine (Prozac), fenfluramine and norfenfluramine, which 
incorporate a CF3-group, could lead to enhanced selectivity and, in the case of fluoxetine, SF5-
substitution enhanced potency vs. some of the 5-HT receptors. The synthesis of SF5-fluoxetine 
started from 4-SF5-nitrobenzene, which was submitted to the usual conversion of the NO2 group into 
Br via reduction to NH2. Nitration occurred in meta to the SF5 affording a substrate highly activated 
towards nucleophilic aromatic substitution, which was reacted with the sodium alcoholate of the 
appropriate -aminoalcohol affording the desired aryl-ether, which was then converted into the 
target compounds (Scheme 99) [114].  
 
Scheme 99 
The SF5-fenfluramine and norfenfluramine were prepared by meta-bromination of 
pentafluorosulfanyl-benzene, which was then lithiated and formylated with DMF. The benzaldehyde 
was condensed with nitroethane and the resulting nitroalkene was reduced to the target products 
(Scheme 100). 
 Scheme 100 
 
A key intermediate in the synthesis of SF5-fluoxetine was also used for the preparation of an SF5-
analogue of the herbicide trifluralin (Scheme 101). Remarkably, the SF5-trifluralin demonstrated 5-
fold greater herbicidal potency relative to the parent CF3-compound. This was rationalised according 
to a favourable interaction of the SF5 residue with a key Thr239 residue of -tubulin, which is 
associated with the electron-rich surface of this group that apparently interacts even more 
favourably than the CF3 [108]. 
 
Scheme 101 
 
Among the first reports of biological activity of SF5-compounds one should also mention the use of 
SF5-CF=CF2 and SF5-CFI-CF3 as effective fumigants, and the insecticidal properties of the non-
fluorinated versions of these compounds [10]. 
Wipf et al. reported the synthesis of 6- and 7-SF5 analogues of Mefloquine, which is an antimalarial 
drug used against chloroquine-resistant Plasmodium falciparum strains. Mefloquine incorporates 
two CF3 groups, one of them in position 8 of the quinoline heterocycle. However the authors initially 
could not access to the exact 8-SF5 mefloquine analogue because the necessary starting material, 
ortho-SF5-nitrobenzene, was not available (Scheme 102). Therefore, meta- and para-SF5-anilines 
were condensed with trifluoroacetoacetate and the resulting 4-hydroxy quinoline was 
dehydroxychlorinated. The resulting 4-chloro-quinolines, which are activated towards nucleophilic 
aromatic substitution, were reacted with metalated 2-pyridyl-acetonitrile and the resulting adducts 
were oxidised delivering the key intermediate pyridyl-ketones, which were eventually submitted to 
PtO2-catalysed hydrogenation to the target SF5-mefloquine analogues. The two molecules were 
tested on different strains of the malaria parasite showing improved activity (IC50s were as low as 3.3 
ng/mL for both isomers) and selectivity towards a mammalian cell line relative to the parent CF3-
substituted mefloquine [110].  
 
Scheme 102 
 
The exact 8-SF5-mefloquine analogue was published by the same group one year later, when ortho-
SF5-aniline became available. Commercially available 3-SF5-phenol was submitted to nitration but 
unfortunately the strong ortho-directing effect exerted by the hydroxyl group afforded poor para-
regioselectivity (Scheme 103). Therefore, the OH was protected as triflate which was nitrated in very 
good yields under total regiocontrol affording the desired para-nitro derivative, which was 
hydrogenated to aniline. Reductive removal of the triflate function proved to be challenging and 
eventually the modification was achieved by treatment with Pd(0)-tetrakis in the presence of formic 
acid and triethylamine. With the key ortho-SF5-aniline in hand the synthesis of 8-SF5-mefloquine was 
performed along the lines previously followed for the 6- and 7-SF5 analogues [116]. This compound 
showed the best balance activity/permeability through blood-brain barrier among the different SF5-
mefloquines. Furthermore, administrated in mice, 8-SF5-mefloquine showed a higher activity than 
mefloquine itself, with a longer half-life (68 h vs 23 h)[117].  
 
 
Scheme 103 
Diederich et al. recently described a rationally-designed SF5-substituted diarylamine as a potential 
antiprotozoal compound. The molecule was obtained from para-SF5-aniline which was used as a 
nucleophile with 2,5-difluoro-nitrobenzene affording a mixture of mono- and di-N-arylation products 
(Scheme 104). The former was isolated and reduced to the corresponding diarylamine, and the 
primary amino group was acylated with 3-chloropropionyl chloride. SN2 reaction with N-methyl-
piperidine provided the target diarylamine, which unfortunately was poorly soluble and could not be 
appropriately tested for its inhibitory properties against the flavoenzyme trypanothione reductase, 
which is an interesting therapeutic target for the treatment of tripanosomatid parasites. Therefore, 
the 3-chloropropyl intermediate was reacted with dimethylamine and the resulting tertiary amine 
was reacted further with 2,4-dichlorobenzyl chloride affording a quaternary ammonium salt. This 
compound showed interesting inhibitory properties with an IC50 = 1.5 M, similar to that displayed 
by the exact analogues having CF3- and tert-butyl groups replacing the SF5. Furthermore, the SF5-
derivative showed the lowest cytotoxicity among all the compounds tested, showing also good 
membrane permeability. Interestingly, switching from CF3 to SF5 the mode of inhibition changed 
from purely competitive to competitive-uncompetitive, respectively. Molecular modelling 
simulations indicated that the SF5-group can effectively occupy the hydrophobic “mepacrine binding 
site” of the receptor [118]. 
 Scheme 104 
A series of SF5- and CF3-substituted selective dopamine D3 antagonists were recently compared both 
in terms of in vitro and in vivo properties (Figure 2). No specific information on the synthesis of these 
SF5-compounds was provided (the CF3-analogues were synthesised in [119]). In general, the two 
series of compounds showed rather similar biological properties in vitro, as well as in vivo [120]. 
 
Figure 2 
Recently, aryl amine-based triazolopyrimidine derivatives incorporating both a CF3 and an SF5 group 
were reported as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors, 
showing antimalarial activity in mice [121]. The substitution of the 4-CF3 group with a 4-SF5 resulted 
in a compound with 2-3-fold better activity against PfDHODH, possibly due to the increase in 
hydrophobicity with SF5 relative to CF3.The SF5-triazolopyrimidine displayed good metabolic stability 
and interesting pharmacokinetic parameters in vivo. Furthermore, it showed good suppression of 
Plasmodium berghei growth in a mouse model, with an ED50 of 17 mg/kg and better efficacy than 
the CF3-compound (Figure 3). 
 
Figure 3 
The compounds above were subsequently optimised and a number of novel derivatives having the 
structure below where synthesised and tested for their ability to inhibit P. falciparum and P. berghei 
DHODH [122]. The compounds having R = CF2CH3 were found to display the highest inhibitory 
potency and the DHODH/CF3-triazolopyrimidine complex was successfully crystallised confirming 
that the CF3 group (and therefore the SF5 group too) occupy a narrow and hydrophobic pocket of the 
enzyme. The two lead compounds were submitted to in vivo tests on SCID mouse P. falciparum 
model for testing their antimalarial efficacy. The SF5-compound was found to have the most potent 
in vivo activity showing remarkable efficacy, with long half life and excellent oral exposure. 
Toxicological studies were not reported, but this SF5-triazolopyrimidine appears to be a very 
promising antimalarial drug candidate. 
 
Figure 4 
5. CONCLUSIONS 
As demonstrated by the body of work reviewed in this article, pentafluorosulfanyl compounds are 
very interesting molecules featuring peculiar chemistry, which remains largely unexplored, and very 
interesting biological properties which go well beyond the analogies with trifluoromethyl-containing 
compounds. It is apparent that the area of SF5-molecules is still in its infancy and important 
breakthroughs concerning both their chemistry and their applications in biomedicine and drug 
discovery might be just around the corner. 
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